Implementation of adaptive methods in early-phase clinical trials-Reference-Cited by-同舟云学术

Implementation of adaptive methods in early-phase clinical trials

Published:2016-02-29 Issue:2 Volume:36 Page:215-224
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Petroni Gina R.¹,Wages Nolan A.¹^ORCID,Paux Gautier²,Dubois Frédéric²

Affiliation:

1. Division of Translational Research and Applied Statistics, Department of Public Health Sciences; The University of Virginia; Charlottesville VA 22908 U.S.A.

2. Oncology Clinical Biostatistics; Institut de Recherches Internationales Servier (IRIS); Suresnes Cedex 92284 France

Funder

National Cancer Institute of the National Institutes of Health

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/sim.6910/fullpdf

Reference32 articles.

1. Design efficiency in dose-finding studies;Paoletti;Computational Statistics and Data Analysis,2004

2. Translation of innovative designs into phase I trials;Rogatko;Journal of Clinical Oncology,2007

3. A comprehensive comparison of the continual reassessment method to the standard 3+3 dose escalation scheme in phase 1 dose-finding studies;Iasonos;Clinical Trials,2008

4. Dose escalation methods in phase I cancer clinical trials;Le Tourneau;Journal of the National Cancer Institute,2009

5. Continual reassessment and related dose-finding designs;O'Quigley;Statistical Science,2010

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of the partial-order continual reassessment method in the early development of treatment combinations;Clinical Trials;2024-03-30

2. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study;BMC Medicine;2023-07-05

3. Concurrent dose-finding of a novel cancer drug with and without a second agent;Journal of Clinical and Translational Science;2023

4. Experimental Medicine Approaches in Early-Phase CNS Drug Development;Advances in Neurobiology;2023

5. Application of the patient-reported outcomes continual reassessment method to a phase I study of radiotherapy in endometrial cancer;The International Journal of Biostatistics;2022-11-17